![Kennet Rooth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kennet Rooth
Voorzitter bij Rare Thyroid Therapeutics International AB
Actieve functies van Kennet Rooth
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Swedish Orphan Biovitrum International AB
![]() Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Verkoop & Marketing | 16-02-2010 | - |
Rare Thyroid Therapeutics International AB
![]() Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Voorzitter | - | - |
Loopbaan van Kennet Rooth
Eerdere bekende functies van Kennet Rooth
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | President | 23-02-2011 | 15-08-2011 |
Verkoop & Marketing | 28-07-2010 | 23-02-2011 | |
Swedish Orphan International Holding AB
![]() Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Verkoop & Marketing | 01-01-2005 | 03-06-2010 |
Opleiding van Kennet Rooth
INSEAD | Undergraduate Degree |
Statistieken
Internationaal
Zweden | 5 |
Frankrijk | 2 |
Operationeel
Sales & Marketing | 3 |
Undergraduate Degree | 1 |
President | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Swedish Orphan International Holding AB
![]() Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Health Technology |
Swedish Orphan Biovitrum International AB
![]() Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Health Technology |
Rare Thyroid Therapeutics International AB
![]() Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Health Technology |
- Beurs
- Insiders
- Kennet Rooth
- Ervaring